Home > Financial Ratios > AUROBINDO PHARMA

AUROBINDO PHARMA
Fixed Capital/Sales

    Back to All Ratios
COMMUNITY POLL
for AUROBINDO PHARMA
Please provide your vote to see the results

AUROBINDO PHARMA Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Fixed Capital/Sales(x) 0.380.350.340.310.27

What is the latest Fixed Capital/Sales ratio of AUROBINDO PHARMA ?

The latest Fixed Capital/Sales ratio of AUROBINDO PHARMA is 0.38 based on Mar2025 Consolidated results.
Year Fixed Capital/Sales
Mar20250.38
Mar20240.35
Mar20230.34
Mar20220.31
Mar20210.27

How is Fixed Capital/Sales of AUROBINDO PHARMA Trending?

Years Fixed Capital/Sales % Change
Mar2025 0.38
8.57
Mar2024 0.35
2.94
Mar2023 0.34
9.68
Mar2022 0.31
14.81
Mar2021 0.27 -

Other Financial Ratios of AUROBINDO PHARMA


Compare Fixed Capital/Sales ratio of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹82,874.9 Cr 0.3% 4.7% 24.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹429,349.0 Cr -3% -1.9% 7.5% Stock Analytics
DIVIS LABORATORIES ₹174,543.0 Cr -3.3% -0.7% -1.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹147,884.0 Cr -3.8% 2.8% 36.4% Stock Analytics
CIPLA ₹111,077.0 Cr -3% 3% -6.1% Stock Analytics
DR REDDYS LABORATORIES ₹105,388.0 Cr -4.3% -2% 2.5% Stock Analytics


AUROBINDO PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

0.3%

4.7%

24.5%

SENSEX

-2.2%

-3.3%

-8.8%


You may also like the below Video Courses